Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Latest filing published 27 May 2015 for Valeant Pharmaceuticals International, Inc..
Insider track record
Disclosed buys
4
Disclosed sells
2
Signal history
No signal scores available.
Closed purchases
Market purchases
4
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Katharine Berghuis Stevenson: trading record in brief
Katharine Berghuis Stevenson is a declared insider at 3 companies; the most frequent names are Valeant Pharmaceuticals International, Inc., OSI Pharmaceuticals Inc and Nortel Networks Corp. Over a trading history stretching from 16 March 2006 to 22 May 2015, the count stands at 22 filings.
On the open market, the record shows 4 purchases worth €320k and 2 sales worth €23k. Taken together, the purchases exceed the sales by €297k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 15 share grants.
Half of the purchases are above €58k and half below.
The latest filing, published on 27 May 2015, reports a share grant in Valeant Pharmaceuticals International, Inc. The most recent open-market purchase was published on 3 December 2014, 4,343 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Katharine Berghuis Stevenson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,607 shares0Common Stock, no par valueSEC:0000885590-15-000043:0
1,500 shares@ US$145.73Common Stock, no par valueSEC:0000885590-14-000080:0
Canonical exit: 3 Mar 2015 (T+90)
2,866 shares0Common Shares, no par valueSEC:0000885590-14-000048:0
4,101 shares@ US$88.21Common Stock, no par valueSEC:0000885590-13-000045:0
3,225 sharesCommon Stock, no par valueSEC:0000885590-13-000041:0
3,873 shares@ US$90.81Common Stock, no par valueSEC:0000885590-13-000041:1
5,022 shares0Common Shares, no par valueSEC:0000885590-13-000033:0
8,062 shares0Common Shares, no par valueSEC:0000885590-12-000043:0
1,000 shares@ US$39.73Common Stock, no par valueSEC:0000885590-11-000052:0
Canonical exit: 6 Nov 2011 (T+90)
4,397 shares0Common Stock, no par valueSEC:0000885590-11-000031:0
2,000 shares@ US$40.59Common Stock, no par valueSEC:0000885590-11-000011:0
Canonical exit: 12 Jun 2011 (T+90)
3,000 shares@ US$25.33Common Shares, no par valueSEC:0000885590-10-000061:0
Canonical exit: 27 Feb 2011 (T+90)
11,490 shares@ US$57.50Common StockSEC:0001127602-10-016865:0
2,500 shares0Common StockSEC:0001127602-09-014282:0
2,500 shares0Common StockSEC:0001127602-08-004229:0
628 shares@ US$25.18Common SharesSEC:0000903423-07-000613:0
1,500 shares0Common StockSEC:0001127602-07-002418:0
4,500 shares0Common SharesSEC:0000903423-07-000319:0
6,188 shares@ US$2.33Common SharesSEC:0000903423-06-001037:0
1,500 shares0Common StockSEC:0001127602-06-001800:0
40,000 shares0Common SharesSEC:0000903423-06-000690:0
357 shares0Common StockSEC:0001209191-06-018933:0
22 of 22 declarations
